Profile
Fortunis Capital is an impact investment firm based in Surrey, United Kingdom, founded in 2018. The firm focuses on investing in innovative and disruptive concepts that deliver positive societal benefits. With a small team of professionals, Fortunis Capital emphasizes impact over exploitation, aiming to support ventures that offer solutions to substantial challenges. The firm collaborates with the UK Government and is an official Home Office Endorsing Body, highlighting its commitment to fostering innovation within the UK.
The firm primarily invests in the UK but seeks opportunities with global applications. Fortunis Capital targets sectors such as biotechnology, healthcare, and energy, with a focus on early-stage ventures. The firm does not specify a typical check size but emphasizes meaningful societal impact through its investments. Fortunis Capital operates with a self-perpetuating deal flow, driven by its active support and strong network.
Notable investments by Fortunis Capital include Stemson Therapeutics - biotechnology, Clementine - healthcare services, and QuickBlock - building products. These investments reflect the firm's mission to improve global society through conscious investment strategies.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.